HK Stock Market Move | EVEREST MED (01952) opened more than 3% higher, with directors and major shareholders increasing their holdings by over 38 million Hong Kong dollars.

Everest Med (01952) opened more than 3% higher, rising 3.03% to 46.2 Hong Kong dollars as of the time of writing with a turnover of 1.8711 million Hong Kong dollars. In terms of news, Everest Med announced that non-executive director and honorary chairman as well as major shareholder Mr. Fu Weigang, executive director and chairman Mr. Wu Yifang, executive director and CEO Mr. Luo Yongqing, and executive director, president, and CFO Mr. He Ying each purchased 339,000 shares, 277,000 shares, 132,500 shares, and 98,200 shares of the company's common stock on the market, with a total price exceeding 38 million Hong Kong dollars with an average price of approximately 45.01 Hong Kong dollars per share. In addition, Cambridge Capital, as a major shareholder of the company, also explicitly stated in the announcement that, considering market conditions and within the limits of applicable laws and regulations, it further commits to increasing its shareholding by no more than 1% over the next three to six months.